Health News

Korean Stem Cell Therapy For Shoulder Arthritis: Medical Tourism Service Expands

The recent expansion from Lydian Cosmetic Surgery Clinic addresses a gap in international medicine for those with shoulder arthritis pain who face prohibitive treatment expenses in their home countries. Offered with bilingual care for international patients, Lydian Cosmetic Surgery Clinic's mesenchymal stem cell therapy treatments help to reduce pain, regenerate tissue, and improve mobility of the shoulder. Interested parties can learn more at https://www.lydianclinic.com/blog/korean-stem-cell-therapy-cost-shoulder-arthritis Financial barriers remain a primary obstacle for patients with degenerative joint conditions. In 2025, 25% of patients surveyed paid more than $20,000 for a single stem cell therapy treatment, according to reporting from The Niche, run by experts at the University of California Davis School of Medicine. These high costs often force reliance on pain management or premature surgical intervention. However, similar treatments in Korea typically cost 40 to 65% less, making the country an attractive medical tourism destination for patients from Southeast Asia, the Middle East, Europe, and North America. In response to this need, Lydian Cosmetic Surgery Clinic provides bilingual coordinators and medical tourism logistics support for non-Korean speakers. Using ultrasound guidance, the Lydian Clinic injects mesenchymal stem cells derived from the patient's own adipose tissue or bone marrow, processed in laboratories that comply with international safety standards, directly into the shoulder. These cells work to repair damaged cartilage, reduce inflammation, improve range of motion, and alleviate chronic pain by addressing underlying tissue degeneration rather than masking symptoms. The team explains that most individuals who receive stem cell therapy at the Lydian Clinic can return to daily activities within one to three days and can fly home within three to five days post-treatment, experiencing only mild soreness or swelling that resolves within 48 to 72 hours. Patients may notice initial improvements within three to six weeks, though the timeline varies depending upon individual factors and condition severity. Continued tissue regeneration occurs over 12 months. Potential stem cell therapy candidates at the Lydian Clinic include those with mild-to-moderate shoulder arthritis, rotator cuff degeneration, or chronic pain unresponsive to physical therapy who wish to preserve joint function and delay or avoid surgery. Candidacy is determined through a free personalized consultation with qualified specialists, as the treatment is not appropriate for severe arthritis requiring joint replacement. For more information, please visit https://www.lydianclinic.com/stemcelleng